Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Adolescent Idiopathic Scoliosis (AIS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 11≤ Adolescents \< 20 years old~* Patient undergoing treatment of AIS by the MID-C system in daily practice~* Minimum of 35 degrees Cobb angle, confirmed by X-ray. Lenke type 1 or 5~* Flexible major curve, correction to below 30° at lateral bending.~* Risser sign of 1 to 5~* Appropriate candidate for posterior surgical approach as determined by surgeon~* Subject has good general health as determined by physician.~* Subject has no known hypersensitivity and allergies to Titanium~* Subject's guardian willing to sign a written Informed Consent Form (ICF)~Exclusion Criteria:~* Cobb angle over 60 degrees~* Other non-idiopathic scoliosis.~* AIS which is not defined as Lenke type 1 or 5~* Previous spine surgery.~* Known allergy to any component of the device.~* Known active systemic disease, such as AIDS, HIV, or active infection~* Systemic disease that would affect the subject's welfare or overall outcome of the study as determined by the physician.~* Mentally compromised as determined by the physician

- Gender: ALL
- Minimum Age: 11 Years
- Maximum Age: 20 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).